NewsAnalysisPodcastsLearningCommunityOpens in new windowJobsOpens in new windowC+D AwardsOpens in new windowDataOpens in new window

Crimes in pharmacies

Partnered Content

Jobs

Find a jobOpens in new window

Post a jobOpens in new window

C+D AwardsOpens in new window

LoginOpens in new window

Data servicesOpens in new window

Pharmacy subscriptions

More

Home

Novo Nordisk invests €432m in Ireland for Wegovy pill production

Mar 04 2026

• By Alex Cooke

It will “support the upgrade and retrofit of the existing facility” and “enhance Novo Nordisk’s capacity to manufacture oral GLP-1s” (Shutterstock)

Additional Topics

Business Weight management Money Ireland Financing

Latest from Business

More from News

Facebook page Twitter feed RSS feed RSS feed

Discover More

C+D Data
C+D Community
C+D Jobs

C+D has been informing, supporting and championing community pharmacy since 1859 and is proud to be at the forefront of providing the latest news to everyone working in the sector.

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Community Principles

Copyright © 2026 Copyright © 2025 Citeline, a Norstella Company. Chemist+Druggist is a trading division of Citeline, a Norstella company and operates as part of C&D Intelligence U.K. Limited. C&D Intelligence U.K. Limited is a company registered in England and Wales (Registration number 13793264) with its registered office at 3 More London Riverside, London SE1 2AQ.